Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10145 (
IL-8
)
23,849
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Erythema nodosum leprosum (ENL) is an inflammatory complication in
leprosy
. Yet, the involvement of ENL neutrophils in the inflammatory response against
Mycobacterium leprae
remains poorly explored. Our primary aim was to investigate the utility of the surface expression of neutrophil IL-10R1 as an ENL biomarker and, secondarily, to evaluate whether
leprosy
or healthy
M. leprae
-stimulated neutrophils produce cytokines and are able to respond to IL-10. We, in this study, describe a subpopulation of circulating neutrophils of ENL patients that exclusively expressed IL-10R1, providing evidence that IL-10R1
+
neutrophils are present in ENL lesions. It was also found that ENL neutrophils, but not those of nonreactional
leprosy
controls, were able to secret detectable levels of TNF ex vivo and the addition of IL-10 blocked TNF release. It was likewise observed that
M. leprae-
stimulated, healthy neutrophils expressed IL-10R1 in vitro, and ENL-linked cytokines were released by
M. leprae
-cultured neutrophils in vitro. Moreover, consistent with the presence of a fully functional IL-10R, the addition of IL-10 prevented the release of
M. leprae
-induced cytokines. Most importantly, dead
M. leprae
revealed its superior capacity to induce
CCL4
and
IL-8
in primary neutrophils over live
Mycobacterium
, suggesting that
M. leprae
may hamper the inflammatory machinery as an immune escape mechanism.
...
PMID:Erythema Nodosum Leprosum Neutrophil Subset Expressing IL-10R1 Transmigrates into Skin Lesions and Responds to IL-10. 3203 84
Multiple pharmacological interventions tested over the last decades have failed to reduce ARDS mortality. This short note recounts past data indicating that (i) neutrophils home along an
IL-8
gradient, (ii) in ARDS, massive neutrophil accumulation and degranulation in and along bronchoalveolar spaces contributes to damage and hypoxia, (iii) large increases in
IL-8
are one of the chemotaxic signals drawing neutrophils to the ARDS lung, and (iv) old data from dermatology and glioblastoma research showed that the old drug against
Hansen's disease
, dapsone, inhibits neutrophils' chemotaxis to
IL-8
. Therefore dapsone might lower neutrophils' contributions to ARDS lung pathology. Dapsone can create methemoglobinemia that although rarely problematic it would be particularly undesirable in ARDS. The common antacid drug cimetidine lowers risk of dapsone related methemoglobinemia and should be given concomitantly.
...
PMID:Dapsone as treatment adjunct in ARDS. 3228 85
<< Previous
1
2
3